In the second episode of this three part series on translational science, Matthew interviews Dr. Chris Austin, CEO of Vesalius Therapeutics about the National Center for Advancing Translational Sciences (NCATS) and what lessons can be learned from its success.
Chris discusses the origins of NCATS, stemming from the ground-breaking insights brought by the completion of the Human Genome Project in 2003. Chris explains how NCATS sought to break down the process of biomedical translation into comprehendible steps that could each be assessed for efficacy and efficiency. Finally, Chris gives examples of some of the "rate limiting steps" in translation that NCATS identified and how the organization tackled these issues.
Throughout all three parts of this interview, Chris references a few papers. Links to each can be found here:
"Translating Translation":
https://ictr.johnshopkins.edu/wp-content/uploads/Translating-Translation-Austin-2018.pdf
"Opportunities and challenges in translational science": https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504824/
"The Fundamental Characteristics of a Translational Scientist":